Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.3K Buy
711
+5
+0.7% +$77 0.01% 199
2026
Q1
$9.54K Buy
706
+106
+18% +$1.48K ﹤0.01% 201
2025
Q4
$7.47K Hold
600
﹤0.01% 218
2025
Q3
$5.94K Hold
600
﹤0.01% 207
2025
Q2
$5.36K Buy
+600
New +$5.07K ﹤0.01% 212

Other funds holding VTRS

Birchbrook's VTRS Position: Q2 2026 in Review

Birchbrook increased its Viatris (VTRS) stake by 0.71% in Q2 2026, buying an estimated $77 and bringing the position to 711 shares worth $11.3K. The position accounts for 0.01% of the portfolio, ranked #199.

Birchbrook first reported a position in VTRS in Q2 2025 and has held it in 5 quarters since. 411 funds tracked by Wall St. Rank hold VTRS as of Q2 2026.

  • Birchbrook held 711 shares of Viatris worth $11.3K as of Q2 2026.
  • Birchbrook bought 5 Viatris shares in Q2 2026, an estimated $77.
  • Viatris made up 0.01% of Birchbrook's portfolio in Q2 2026, its #199 holding.
  • Birchbrook first reported a position in Viatris in Q2 2025 and has held it in 5 quarters since.
  • 411 funds tracked by Wall St. Rank held Viatris as of Q2 2026.

Based on Birchbrook's 13F filing for Q2 2026, filed 9 Jul 2026.